VASP and laryngotracheoesophageal cleft: As the specific molecular mechanisms of VASP and LC and the regulation of proliferation, migration, invasion, and apoptosis of LC cells have not been thoroughly studied, it cannot be conclusively stated whether VASP can be applied in clinical treatment or used as a new tumor marker.